Aditxt, Inc.
ADTX • NASDAQ
Aditxt, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Amro A. Albanna, with a market cap of $1.1M.
CEOAmro A. Albanna
Next Earnings
Upcoming earnings announcement for Aditxt, Inc.
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for Aditxt, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 18, 2025 | Q3 2025 | -$548.78 | — | $748.0K | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$3.45 | — | $1.0K | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$8.12 | — | $1.0K | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$2,539.65 | — | $3.2K | — | 10-K |
| Nov 18, 2024 | Q3 2024 | -$111.07 | — | $6.9K | — | 10-Q |
| Aug 19, 2024 | Q2 2024 | -$167.60 | — | $44.3K | — | 10-Q |
| May 20, 2024 | Q1 2024 | -$365.60 | — | $79.7K | — | 10-Q |
| Apr 16, 2024 | Q4 2023 | -$603.85Est: -$1,192.40 | +49.4% | $81.3KEst: $140.0K | -41.9% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$1,950.80Est: -$239.60 | -714.2% | $124.5KEst: $300.0K | -58.5% | — |
| Aug 14, 2023 | Q2 2023 | -$1,472.00Est: -$4,624.00 | +68.2% | $221.0KEst: $360.0K | -38.6% | 10-Q |
| May 15, 2023 | Q1 2023 | -$2,096.00Est: -$4,448.00 | +52.9% | $218.4KEst: $340.0K | -35.8% | — |
| Apr 17, 2023 | Q4 2022 | -$4,992.00 | — | $185.6K | — | — |